Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Using mild intermittent hypoxia to prevent autonomic dysfunction in spinal cord injury patients

Official title: Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals With Spinal Cord Injuries

Run by VA Office of Research and Development · NCT05351827 · Data updated 2026-11-12

This study is testing if mild intermittent hypoxia can help people with spinal cord injuries improve their blood pressure control and overall health by preventing autonomic dysfunction.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment24 (estimated)
SponsorVA Office of Research and Development
Federal
Locations1 site (Detroit, Michigan)
StatusRecruiting
StartedOctober 1, 2022
Main results expectedOctober 29, 2027
Study endsOctober 29, 2027
Registry record updatedAugust 14, 2026
Trial IDNCT05351827 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-60 with motor incomplete spinal cord injuries at or above the 12th thoracic vertebrae who exhibit signs of autonomic dysfunction.

Probably not a fit

Patients with complete spinal cord injuries or those with other significant health issues such as insulin-dependent diabetes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of mild intermittent hypoxia (MIH) as a preventive measure for autonomic dysfunction in individuals with spinal cord injuries (SCI). Patients with SCI above the 6th thoracic vertebrae often experience severe autonomic dysfunction, leading to conditions like autonomic dysreflexia and orthostatic hypotension. The study aims to determine if exposure to MIH can restore blood pressure control and improve overall health outcomes for these patients. Participants will be monitored for changes in autonomic function and related health metrics during the intervention.

Why it matters

Potential benefit: If successful, this approach could significantly improve blood pressure control and reduce cardiovascular risks for patients with spinal cord injuries.

How similar studies have gone: While the use of mild intermittent hypoxia is a novel approach in this context, similar interventions have shown promise in improving health outcomes in other populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Motor incomplete spinal cord injury at or above the 12th thoracic vertebrae
* Signs or symptoms of autonomic dysfunction (this will be determined by the Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) and ISAFSCI questions. The ADFSCI requires a score of 1 on questions 16 and 22, and the International Standards to document Autonomic Function following SCI (ISAFSCI) requires a score of 1 on any parameter)
* Chronic injuries (\>1 year post injury)

Exclusion Criteria:

* Pregnant
* Smoker
* Drug addiction
* Complete spinal cord injury
* Spinal cord injury below the 6th thoracic vertebrae
* Insulin dependent diabetes
* Shift workers (i.e., disrupted circadian rhythm)
* Active skin breakdown or pressure sores

Where it's running

  • John D. Dingell VA Medical Center, Detroit, MI
    Detroit, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: Gino Panza, PhD — John D. Dingell VA Medical Center, Detroit, MI
  • Study coordinator: Gino Panza, PhD
  • Email: Gino.Panza@va.gov
  • Phone: (313) 576-1000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.